The board of directors of Lansen Pharmaceutical Holdings Limited announced that Dr. Zhu Xun has been appointed as an Independent Non-executive Director and a member of the Remuneration Committee of the Company with effect from 23 September 2022. Dr. Zhu, age 63, is a native of Changchun City. From 1995 to 2000, he served as the vice principal of Norman Bethune University of Medical Science.

From 2000 to 2003, he served as deputy secretary general of the Changchun Municipal Government and from 2004 to 2006, he served as special assistant to the mayor of Changchun Municipal Government. From April 2003 to June 2020, he was a former director of certain subsidiaries of Cathay International Holdings Limited, an ultimate holding company of the Company. Dr. Zhu has over 20 years of experience in the pharmaceutical industry.

He is currently the Honorary Chairman of the Board of Directors of the Tongxieyi New Drugs Talent Club, the Chief of Medicine and Strategy, the Honorary Principal of Shell University, and Associate Chief Editor of the magazine Progress in Pharmaceutical Sciences. He is also an independent non-executive director of Sihuan Pharmaceutical Holdings Group Limited (stock code: 460), an independent director of Shenzhen ChipScreen BioS (stock code on sci-tech innovation board: 688321), a senior consultant of Changchun Jinsai Pharmaceutical and Shenzhen Osa Pharmaceutical. Pursuant to the letter of appointment entered into between the Company and Dr. Zhu, the appointment of Dr. Zhu is for a term of three years commencing from 23 September 2022.